Brimonidine Tartrate Solution/ Drops
Product Images NDC 42571-462

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 42571-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimo-crtn.jpg (Brimo Crtn)

Packaging label for Brimonidine Tartrate Ophthalmic Solution 0.1%, a sterile eye drop solution. The label indicates the product is for prescription use only, contains 5 mL per bottle, and is manufactured by Micro Labs Limited. It includes storage instructions and lists inactive ingredients alongside the active ingredient brimonidine tartrate USP 0.1%.*

FDA Label Image

Brimo-lbl.jpg (Brimo Lbl)

Label for Brimonidine Tartrate Ophthalmic Solution 0.1% in a 5 mL bottle. The label indicates it is for eye use only and sterile. It includes storage instructions and dosage information, with Micro Labs USA, Inc. as the manufacturer and a noted manufacturing origin of India.*

FDA Label Image

Brimo-str.jpg (Brimo Str)

Chemical structure of brimonidine tartrate, shown as two distinct molecular components. The first molecule features a brominated bicyclic structure with nitrogen atoms, while the second represents the tartrate portion with hydroxyl and carboxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.